Limited coverage drugs – ticlopidine

Last updated on March 24, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	ticlopidine
Strength & form	250 mg tablet

Special Authority criteria	Approval period
For use in secondary prevention of coronary, cerebral and peripheral vascular occlusion and embolization where patient has experienced failure on or intolerance to ASA	Indefinite

Practitioner exemptions

None

Special notes

None

Special Authority request form(s)

Log in to eForms
HLTH 5328 – Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – ticlopidine

Generic name

Strength & form

Special Authority criteria

Approval period

Practitioner exemptions

Special notes

Special Authority request form(s)